Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
Emma Wall, Mary Wu, Ruth Harvey, et al.
The Lancet (2021) Vol. 397, Iss. 10292, pp. 2331-2333
Open Access | Times Cited: 549

Showing 1-25 of 549 citing articles:

Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2532
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas, David Veyer, Artem Baidaliuk, et al.
Nature (2021) Vol. 596, Iss. 7871, pp. 276-280
Open Access | Times Cited: 2027
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
Yinon M. Bar-On, Yair Goldberg, Micha Mandel, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 15, pp. 1393-1400
Open Access | Times Cited: 1151
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
John S. Tregoning, Katie E. Flight, Sophie L. Higham, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 10, pp. 626-636
Open Access | Times Cited: 1056
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 993
Waning Immunity after the BNT162b2 Vaccine in Israel
Yair Goldberg, Micha Mandel, Yinon M. Bar-On, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24
Open Access | Times Cited: 670
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
Akatsuki Saito, Takashi Irie, Rigel Suzuki, et al.
Nature (2021) Vol. 602, Iss. 7896, pp. 300-306
Open Access | Times Cited: 556
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1161-1179
Open Access | Times Cited: 552
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
Mark G. Thompson, Karthik Natarajan, Stephanie A. Irving, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 4, pp. 139-145
Open Access | Times Cited: 397
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Franz X. Heinz, Karin Stiasny
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 348
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
The Lancet Microbe (2021) Vol. 3, Iss. 1, pp. e52-e61
Open Access | Times Cited: 342
Covid‐19 vaccines and variants of concern: A review
Ikbel Hadj Hassine
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Open Access | Times Cited: 323
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study
Julia Hippisley‐Cox, Carol Coupland, Nisha Mehta, et al.
BMJ (2021), pp. n2244-n2244
Open Access | Times Cited: 283
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 220
Impact of the Delta variant on vaccine efficacy and response strategies
Lianlian Bian, Qiushuang Gao, Fan Gao, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1201-1209
Open Access | Times Cited: 218
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
Maria Pia Sormani, Matilde Inglese, Irene Schiavetti, et al.
EBioMedicine (2021) Vol. 72, pp. 103581-103581
Open Access | Times Cited: 213
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 208
The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
Dandan Tian, Yanhong Sun, Jianming Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 192
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
Gary R. McLean, Jeremy P. Kamil, Benhur Lee, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 179
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination
Christopher Davis, Nicola Logan, Grace Tyson, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 12, pp. e1010022-e1010022
Open Access | Times Cited: 174
Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
Benjamin Israelow, Tianyang Mao, Jon Klein, et al.
Science Immunology (2021) Vol. 6, Iss. 64
Open Access | Times Cited: 173
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna Patel, Kishu Ranjan
Biomolecules (2021) Vol. 11, Iss. 7, pp. 993-993
Open Access | Times Cited: 169
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
Annika Fendler, Scott T.C. Shepherd, Lewis Au, et al.
Nature Cancer (2021) Vol. 2, Iss. 12, pp. 1305-1320
Open Access | Times Cited: 164
Immunity to SARS‐CoV‐2 induced by infection or vaccination
Xaquín Castro Dopico, Sebastian Ols, Karin Loré, et al.
Journal of Internal Medicine (2021) Vol. 291, Iss. 1, pp. 32-50
Open Access | Times Cited: 156
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Jalen Singh, Pranav Pandit, Andrew G. McArthur, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 141
Page 1 - Next Page

Scroll to top